Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-10,500
Closed -$1.42M 5519
2024
Q3
$1.42M Buy
+10,500
New +$1.4M ﹤0.01% 3125
2020
Q2
Sell
-2,100
Closed -$137K 6341
2020
Q1
$137K Buy
2,100
+1,800
+600% +$142K ﹤0.01% 4567
2019
Q4
$24K Sell
300
-27,000
-99% -$2.1M ﹤0.01% 5943
2019
Q3
$2.17M Buy
27,300
+26,600
+3,800% +$2.09M ﹤0.01% 2760
2019
Q2
$59K Buy
700
+200
+40% +$15.9K ﹤0.01% 6020
2019
Q1
$40K Sell
500
-1,500
-75% -$109K ﹤0.01% 6031
2018
Q4
$133K Sell
2,000
-2,400
-55% -$166K ﹤0.01% 4855
2018
Q3
$351K Sell
4,400
-700
-14% -$52.3K ﹤0.01% 4561
2018
Q2
$344K Buy
5,100
+4,700
+1,175% +$341K ﹤0.01% 4273
2018
Q1
$31K Hold
400
﹤0.01% 6226
2017
Q4
$27K Sell
400
-1,900
-83% -$126K ﹤0.01% 6142
2017
Q3
$144K Buy
2,300
+500
+28% +$29.9K ﹤0.01% 4672
2017
Q2
$100K Sell
1,800
-2,400
-57% -$125K ﹤0.01% 4910
2017
Q1
$211K Buy
4,200
+400
+11% +$19.5K ﹤0.01% 4262
2016
Q4
$188K Sell
3,800
-15,300
-80% -$776K ﹤0.01% 4266
2016
Q3
$1M Buy
19,100
+17,400
+1,024% +$853K ﹤0.01% 2620
2016
Q2
$76K Sell
1,700
-400
-19% -$17.4K ﹤0.01% 4587
2016
Q1
$84K Buy
2,100
+2,000
+2,000% +$73.6K ﹤0.01% 4474
2015
Q4
$4K Sell
100
-400
-80% -$14.5K ﹤0.01% 5632
2015
Q3
$16K Sell
500
-100
-17% -$3.37K ﹤0.01% 5572
2015
Q2
$22K Sell
600
-500
-45% -$18.2K ﹤0.01% 5629
2015
Q1
$39K Sell
1,100
-6,400
-85% -$226K ﹤0.01% 5448
2014
Q4
$285K Sell
7,500
-1,800
-19% -$65.8K ﹤0.01% 4358
2014
Q3
$326K Buy
9,300
+6,900
+288% +$256K ﹤0.01% 4331
2014
Q2
$94K Hold
2,400
﹤0.01% 5457
2014
Q1
$86K Sell
2,400
-4,700
-66% -$171K ﹤0.01% 5574
2013
Q4
$241K Sell
7,100
-1,900
-21% -$61.1K ﹤0.01% 4837
2013
Q3
$243K Sell
9,000
-1,100
-11% -$29.3K ﹤0.01% 4846
2013
Q2
$272K Buy
+10,100
New +$279K ﹤0.01% 4880

Other funds holding XYL

Barclays's XYL Position: Q1 2026 in Review

Barclays increased its Xylem (XYL) stake by 30% in Q1 2026, buying an estimated $22.6M and bringing the position to 739,023 shares worth $88.3M. The position accounts for 0.02% of the portfolio, ranked #531.

Barclays first reported a position in XYL in Q2 2013 and has held it in 52 quarters since. The position peaked at $98.5M in Q3 2025. 1,108 funds tracked by Wall St. Rank hold XYL as of Q1 2026.

  • Barclays held 739,023 shares of Xylem worth $88.3M as of Q1 2026.
  • Barclays bought 172,190 Xylem shares in Q1 2026, an estimated $22.6M.
  • Xylem made up 0.02% of Barclays's portfolio in Q1 2026, its #531 holding.
  • Barclays first reported a position in Xylem in Q2 2013 and has held it in 52 quarters since.
  • Barclays's Xylem position peaked at $98.5M in Q3 2025.
  • 1,108 funds tracked by Wall St. Rank held Xylem as of Q1 2026.

Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.